Vitamin D deficiency in women of reproductive age, options for correction
https://doi.org/10.21518/2079-701X-2018-7-18-22
Abstract
Vitamin D deficiency is the pandemica for real in the modern world [1]. The role of vitamin D in the reproductive function regulation has been proven in light of the achievements over the past few years. Being a steroid hormone, this vitamin is essential for a wide range of normal physiologic functions. Vitamin D insufficiency as defined by serum 25(OH)D ≤ 30 ng/ml is widespread globally, with the frequency of registration of this condition among the population of Russia over 90% [2]. The elderly and pregnant women (especially in the presence of fat metabolism disorders, gestational diabetes and infectious pathology), who did not undergo a vitamin correction medication, is the main risk group for vitamin D deficiency. Objective of the study: Evaluate the efficacy of colcalciferol in vitamin D-deficient therapy in women of reproductive age. Material and methods of the study: clinical and laboratory examination and treatment of 31 patients with various reproductive system pathologies, aged 21 to 45 years who were hospitalized to the Department of Gynaecology. In addition to the general clinical examination, all patients had their vitamin D, total and ionized calcium levels in blood plasma assessed. In order to correct the vitamin D deficiency and insufficiency, the vitamin D supplementation by colcalciferol (vitamin D3) intake was prescribed to all examined patients in addition to the treatment of the underlying disease. Results of the study: all examined patients showed the decreased vitamin D concentration in the blood plasma below the reference indices. The vitamin D deficiency was discovered in 64.5% cases. At the same time, a significant increase in the concentration of 25(OH)D3 in blood plasma was noted against the background of therapy.
About the Authors
A. Z. KhashukoevaRussian Federation
MD, Prof
T. N. Savchenko
Russian Federation
MD, Prof
M. I. Agaeva
Russian Federation
PhD in medicine
Z. A. Agaeva
Russian Federation
G. O. Andreasyan
Russian Federation
PhD in medicine
T. V. Netudykhatko
Russian Federation
L. H. Heydar
Russian Federation
PhD in medicine
References
1. Bischoff-Ferrari HA, Burckhardt P, Quack-Loetscher K, Gerber B, I’Allemand D, Laimbacher J, Bachmann M, Rizzoli R. Vitamin D deficiency: Evidence, safety, and recommendations for the Swiss population. Report written by a group of experts on behalf of the Federal Commission for Nutrition (FCN) 2012. http://www.iccidd.org/ p142000804.html.
2. Karonova TL, Grineva EN, Nikitina IL, Tsvetkova EV, Todieva AM, Belyaeva OD, Mikheeva EP, Globa P. Yu, Andreeva AT, Beletskaya IS, Omelchuk NV, Fulonova LS, Shlyakhto EV. The prevalence of vitamin D deficiency in the North-West region of Russia among St. Petersburg and Petrozavodsk residents. Osteoporoz i Osteopatii, 2013, 3: 3-7.
3. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 2011, 96(7): 1911-1930.
4. Kinuta K, Tanaka H, Moriwake T, Aya K, Kato S, Seino Y. Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinol, 2000, 141: 1317-1324.
5. Castro LC. The vitamin D endocrine system. Arq Bras Endocrinol Metabol, 2011, 55(8): 566-575.
6. Dedov II, Ilnichenko IA. Clinical guidelines on vitamin D deficiency in adults: diagnosis, treatment and prevention. M., 2015. 75 p.
7. Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiological Reviews, 1998, 78: 1193-1231.
8. Jenster G, Spencer TE, Burcin MM, Tsai SY, Tsai MJ, O’Malley BW. Steroid receptor induction of gene transcription: a two-step model. PNAS, 1997, 94: 7879-7884.
9. Wehr E, Pilz S, Schweighofer N et al. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol, 2009, 161: 575-582.
10. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocrine Reviews, 2008, 29: 720-726.
11. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academy Press, 2010.
12. Blomberg JM, Dissing S. Non-genomic effects of vitamin D in human spermatozoa. Steroids, 2012, 77(10): 903-909.
13. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol, 2014, 2: 76-89.
14. Pleshcheva AV, Pigarova EA, Dzeranova LK. Vitamin D and metabolism: facts, myths and prejudices. Ozhirenie i Metabolizm, 2012, 2: 33-42.
Review
For citations:
Khashukoeva AZ, Savchenko TN, Agaeva MI, Agaeva ZA, Andreasyan GO, Netudykhatko TV, Heydar LH. Vitamin D deficiency in women of reproductive age, options for correction. Meditsinskiy sovet = Medical Council. 2018;(7):18-22. (In Russ.) https://doi.org/10.21518/2079-701X-2018-7-18-22